Effective argumentation often missing from clinical research reports

Much of clinical research reporting associated with regulatory submission strategies must be persuasive writing. In particular, discussions about the significance of study findings and how these findings directly support development claims. To win the point of persuasion, such writing must follow conventions of well-framed arguments that avoid rhetorical flaws.

I've been doing quite a bit of work over the past two months with groups who are responsible for producing clinical research reports. Reflecting back on my work, I find that many involved in authoring or reviewing these documents do not recognize the elements that contribute to effective arguments. They often confuse summaries of study findings as being meaningful conclusions about the significance of research findings.

One of the common rhetorical flaws is that authoring teams are comfortable making broad generalizations and see such generalizations as being solid conclusions and part of well-framed arguments. Broad generalizations seldom stand scrutiny of regulatory review and the generalizations of truly difficult and controversial topics never withstand close scrutiny. Faulty generalizations are easy to spot. For instance terms like......"generally well tolerated;" "suggests relevant differences;" and "may be associated with" appear throughout discussion and conclusion sections of many clinical research reports.

Originally published on our Knowledge Managment blog